Cargando…

Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data

INTRODUCTION: In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study's primary objective was to determine racial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caballero, Joshua, Xu, Jianing, Hall, Daniel B., Chen, Xianyan, Young, Henry N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association of Psychiatric Pharmacists 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583257/ https://www.ncbi.nlm.nih.gov/pubmed/37860586 http://dx.doi.org/10.9740/mhc.2023.08.183

Ejemplares similares

Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
por: Voss, Erica A., et al.
Publicado: (2015)

Racial and Ethnic Disparities in Long-Acting Injectable Antipsychotic Use in a National Sample of Medicare Beneficiaries With Schizophrenia
por: Li, Pengxiang, et al.
Publicado: (2023)

Extent of use of long-acting injectable antipsychotics in children and adolescents within Indiana Medicaid
por: Modesitt, Taylor, et al.
Publicado: (2018)

Racial/Ethnic Patterns in Opioid Dispensing among Medicaid-Funded Young Children
por: Sivaraj, Laksika B., et al.
Publicado: (2023)

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
por: Miyamoto, Seiya, et al.
Publicado: (2017)

Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
por: Mahlich, Jörg, et al.
Publicado: (2020)

High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders
por: Auxilia, Anna Maria, et al.
Publicado: (2023)

Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study
por: Patel, Aarti A., et al.
Publicado: (2023)

Ethnic and Age Disparities in Patients Taking Long-acting Injectable Atypical Antipsychotics
por: Soleman, Mateen, et al.
Publicado: (2017)

Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
por: Janzen, Donica, et al.
Publicado: (2022)

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
por: Pilon, Dominic, et al.
Publicado: (2017)

Racial and ethnic disparities in workers’ compensation claims rates
por: Smith, Caroline K., et al.
Publicado: (2023)

Racial/Ethnic Differences in the Pharmacokinetics of Antipsychotics: Focusing on East Asians
por: Lin, Shih-Ku
Publicado: (2022)

Does Medicaid Managed Care Help Equalize Racial and Ethnic Disparities in Utilization?
por: Marton, James, et al.
Publicado: (2015)

Medicaid Expansion and Racial/Ethnic Differences in Readmission After Acute Ischemic Stroke
por: McGee, Blake T., et al.
Publicado: (2021)

The effect of differential privacy on Medicaid participation among racial and ethnic minority groups
por: Kurz, Christoph F., et al.
Publicado: (2022)

Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10
por: Tatini, Lorenzo, et al.
Publicado: (2021)

The use of long-acting injectable antipsychotics in an acute psychiatric unit
por: Ortega-Hernández, G., et al.
Publicado: (2023)

Racial and ethnic disparities in oral healthcare quality among children enrolled in Medicaid and CHIP
por: Herndon, Jill Boylston, et al.
Publicado: (2022)

Attitudes of European physicians towards the use of long-acting injectable antipsychotics
por: Patel, Maxine X., et al.
Publicado: (2020)

Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
por: Riboldi, Ilaria, et al.
Publicado: (2022)

T213. TREND OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS USE IN ASIA: FINDINGS FROM REAP ANTIPSYCHOTIC STUDIES
por: Lin, Shih-Ku, et al.
Publicado: (2020)

Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review
por: Kishi, Taro, et al.
Publicado: (2021)

National racial/ethnic and geographic disparities in experiences with health care among adult Medicaid beneficiaries
por: Martino, Steven C., et al.
Publicado: (2019)

Racial And Ethnic Disparities In Patient Experience Of Care Among Nonelderly Medicaid Managed Care Enrollees
por: Nguyen, Kevin H., et al.
Publicado: (2022)

Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients
por: Kamat, Siddhesh A, et al.
Publicado: (2015)

Increased Healthcare Resource Use and Costs After Discontinuation of Liraglutide in Patients with Type 2 Diabetes from a Commercial- and Medicaid-Insured Claims Database
por: Uzoigwe, Chioma, et al.
Publicado: (2022)

Rates of Diabetes-Related Major Amputations Among Racial and Ethnic Minority Adults Following Medicaid Expansion Under the Patient Protection and Affordable Care Act
por: Tan, Tze-Woei, et al.
Publicado: (2022)

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
por: Llorca, Pierre Michel, et al.
Publicado: (2013)

Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophrenia
por: Stevens, Georgia L., et al.
Publicado: (2015)

Comparison of Efficacy and Safety between Long-Acting Injectable Antipsychotic Monotherapy and Combination of Long-Acting Injectable and Oral Antipsychotics in Patients with Schizophrenia
por: Sathienluckana, Thanompong, et al.
Publicado: (2021)

Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
por: Citrome, Leslie
Publicado: (2009)

Predicting Blood Glucose Concentration after Short-Acting Insulin Injection Using Discontinuous Injection Records
por: Tang, Baoyu, et al.
Publicado: (2022)

Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States
por: Nephew, Lauren D., et al.
Publicado: (2020)

The association of Medicaid expansion and racial/ethnic inequities in access, treatment, and outcomes for patients with acute myocardial infarction
por: Valdovinos, Erica M., et al.
Publicado: (2020)

Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics
por: Stam, Noraly, et al.
Publicado: (2020)

Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychotics
por: Kheloussi, Steven, et al.
Publicado: (2022)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Long-acting injectable antipsychotics: focus on olanzapine pamoate
por: Lindenmayer, JP
Publicado: (2010)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rn6njl92qqsbamcqvagquicujn